Overview

Eptinezumab in Participants With Episodic Cluster Headache

Status:
Recruiting
Trial end date:
2023-07-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of eptinezumab in participants with episodic Cluster Headache (eCH)
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S